Skip to main content

More Evidence Backs CBD For Kids' Rare Epilepsy

WebMD

TUESDAY, April 30, 2019 (HealthDay News) — There’s new data supporting the use of Epidiolex — the first cannabidiol (CBD) medicine approved by the U.S. Food and Drug Administration — to help curb a form of epilepsy.

The research found that the drug reduced seizures by nearly half in children with Dravet syndrome, a rare and severe form of the neurological disorder.

The FDA approved Epidiolex last fall for the treatment of Dravet syndrome and another rare but severe form of childhood epilepsy, Lennox-Gastaut syndrome. The new study was funded by GW Research Ltd., developer of Epidiolex.

Dravet syndrome typically begins in infancy and can lead to intellectual disability and frequent, prolonged seizures, noted a team of researchers led by Dr. Ian Miller, from Nicklaus Children’s Hospital in Miami.

“It’s exciting to be able to offer another alternative for children with this debilitating form of epilepsy and their families,” Miller said. He and his colleagues will present their findings next week at the American Academy of Neurology’s annual meeting, in Philadelphia.

“The children in this study had already tried an average of four epilepsy drugs with no success and at the time were taking an average of three additional drugs, so to have this measure of success with cannabidiol is a major victory,” Miller said in a meeting news release.

The study included 199 patients, average age 9, who were divided into three groups. One group received 20 milligrams per kilogram (mg/kg) dose per day of Epidiolex (in liquid form), while the second group received 10 mg/kg per day, and the third group received a placebo.

CBD products are derived from marijuana, but do not include THC, the active agent in pot that causes a “high.”

After 14 weeks of treatment, seizures with convulsions fell 46% in the high-dose group, 49% in the low-dose group, and 27% in the placebo group.

Total seizures fell 47% in the high-dose group, 56% in the low-dose group, and 30% in the placebo group.

Seizures were reduced by half or more in 49% of the high-dose group, 44% of the low-dose group, and 26% of the placebo group.

Original Article Source: https://www.webmd.com/epilepsy/news/20190430/more-evidence-backs-cbd-for-kids-rare-epilepsy?src=RSS_PUBLIC

Comments

Popular posts from this blog

Mormon Church Faces Potential Lawsuit Over Medical Marijuana Opposition

Political committees concerned with marijuana law reform in four states have waged an information war over the past year, first to qualify cannabis initiatives for the ballot, and then to support or oppose those measures in the lead-up to last week’s midterm elections. In total, over  $12.9 million in cash and in-kind services was spent attempting to convince voters about these marijuana ballot measures. Now that voters have had their say, Marijuana Moment decided to calculate how much each “yes” and “no” vote cost the committees on either side of the debate. Our calculations are based on dollars raised and disclosed before the election, since final totals of actual expenditures won’t be available until December or January reports required in the states that voted on cannabis. Michigan In Michigan, where voters approved marijuana legalization , our calculations show that the two anti-legalization committees spent about $1.28 per “no” vote, as they raised $2.37 million for ...

Mississippi Lawmakers Put Competing Medical Marijuana Measure On Ballot, Frustrating Advocates

A congressional committee approved two bills focused on marijuana and military veterans on Thursday. The action is the first markup of cannabis-related legislation on Capitol Hill this year. The bills approved by the House Veterans’ Affairs Committee are geared toward expanding access to medical cannabis for the veteran population and increasing research into the plant’s therapeutic benefits for conditions such as chronic pain and post-traumatic stress disorder (PTSD). The Veterans Equal Access Act, sponsored by Rep. Earl Blumenauer (D-OR), would allow doctors at the U.S. Department of Veterans Affairs (VA) to recommend medical marijuana to their patients in states where it’s legal. It was approved in a vote of 15-11. “Today was a monumental day for our veterans. We have been working for years to reform this counterproductive policy that forces veterans outside of the VA to receive legal medical cannabis treatment for chronic pain and PTSD,” Blumenauer said after the vote. “This is...

NY Dem Chair Warns Against Passing Voter-Supported Marijuana Legalization Bill

The head of New York’s Democratic Party said on Thursday that if the state Senate votes on a marijuana legalization bill, his party’s lawmakers run the risk of alienating voters and losing reelection next year. Jay Jacobs, the state party chairman, claimed that several “far progressive” measures, including cannabis legalization, lack popularity in certain areas across the state such as Long Island and upstate New York. He cautioned lawmakers against putting the issue to a vote, arguing that voters would “throw us out of office.” “It could be the straw that breaks the camel’s back,” he told Newsday. Polling doesn’t support that conclusion, though. According to a March 2019 survey from Quinnipiac, 65 percent of New Yorkers are in favor of allowing adults to legally possess cannabis for personal use. That includes 63 percent of respondents in upstate New York and 65 percent of those living in the suburbs. Sixty-six percent of independents statewide also back ending marijuana prohibit...